PROTECTION APPARATUS FOR PATIENT-IMPLANTABLE DEVICE

Abstract: An electrical circuit is connected in series with a lead (13) of an implantable heart pacemaker (10) between the pacemaker and the heart (11) to protect the pacemaker against high voltages and currents produced by defibril­ lators (17) and other sources. The electrical circuit has a sensing resistor (24) arranged between two normally conduct­ ing field effect transistors (FETs) (22, 23) all in electrical series with the pacemaker lead (13). When the voltage drop across the sensing resistor (24) exceeds a predetermined positive or negative amplitude, a transistor becomes conductive and turns off the normal conduction channels of the FETs. An alternate, electrically conductive high-impedance path is switched in to limit the current flow to the pacemaker until the magnitude of the voltage across the sensing resistor drops to a safe level. The transistor then becomes non-conductive and the FETs become conductive re-establishing the normal low-impedance conduction path and effectively switching the alternate high-impendance path out of the circuit.

Description: BACKGROUND OF THE INVENTION The invention disclosed herein relates gener­ ally to protection devices used to protect other de­ vices from damage or destruction resulting from voltage or current surges. In particular, the present inven­ tion relates to such a protection device which is im­ plantable in the body of a patient with a heart pacemaker to protect the pacemaker against current surges, par­ ticularly those resulting from the operation of an external or implanted heart defibrillator. It is well known that in many instances an implanted heart pacemaker can successfully regulate the otherwise faulty operation of a damaged or diseased heart. Generally, a typical pacemaker senses electrical activity or lack of such activity in the heart muscle, and supplies electrical stimulus pulses to the heart to stimulate contractions when necessary. The electrical stimulus pulses generated by a pacemaker, however, are ineffective to stop the lethal condition of fibrilla­ tion. However, it is well known that the application of a series of high-voltage pulses to the heart is often effective in arresting fibrillation. Of course it is desirable following defibrillation of the heart for the pacemaker to resume its normal regulatory role. A serious problem in this regard, however, is that with­ out adequate protection against the large current flow induced by the application of high-voltage defibrilla­ tion pulses to the heart, a pacemaker can be damaged or destroyed. Obviously, from the standpoint of the pat­ ient's continued well being, this is a totally unaccep­ table consequence. In the past, a number of attempts have been made to provide adequate protection against excessive currents and voltages for pacemakers and other medical devices such as electrocardiogram (ECG) amplifiers. For example, it is known to connect one or more zener diodes between the opposite leads of a pacemaker to limit the voltage differential therebetween. However, as discussed in U.S. Patent No. 4,320,763 to Money, this approach is not effective to limit the current flow between the heart tissue and the electrode at the distal end of the pacemaker lead. As a result, the heart tissue near the point of contact with the electrode can be severely damaged when high-­ voltage defibrillation pulses are applied to the heart. The '763 patent discloses that such tissue damage can be prevented by connecting a current limiting device such as a diode or a pair of field effect transistors (FETs) in series between a pacemaker output terminal and a distal electrode. However, it is apparent that the current limiting device thereby becomes a permanent part of the pacemaker circuit. When current limiting is not needed, for example during normal pacing opera­ tion, it is desirable to remove the current limiting device from the circuit to avoid unnecessary noise gener­ ation as well as loading effects. An approach for protecting the pacemaker cir­ cuitry itself is disclosed in U.S.. Patent No. 4,440,172 to Langer. The '172 patent discloses an implantable pacemaker and defibrillator unit in which the pacemaker and defibrillator share common output and return lines. The pacemaker generates negative-going stimulus pulses and is protected against the positive-going high-voltage defibrillator pulses by a resistor and forward biased diode connected in series between the common output line and ground. This approach only provides limited protection to the pacemaker from unidirectional defibril­ lation pulses. Recent medical research has shown, however, that a number of benefits are obtained by using a bidirectional or "biphasic" pulse train to defibrillate the heart. Some of the benefits of "biphasic" defibril­ lation, which forms no part of the present invention, are discussed in Schuder, Defibrillation of 100kg Calves With Asymmetrical, Bidirectional, Rectangular Pulses, Cardiovascular Research 419-426 (1984), and Jones, Decreased Defibrillator-Induced Dysfunction With Biphasic Rectangular Waveforms , Am. J. Physiol. 247 (Heart Circ. Physiol. 16): H792-H796 (1984). U.S. Patent No. 3,886,932 to Suessmilch dis­ closes an approach in which a small sampling resistor is connected in series with a pacemaker lead. The resistor voltage is compared to a preselected reference voltage. If the resistor voltage exceeds the reference voltage, a switch in series with the resistor and lead is opened for a preselected period of time, after which it is closed and the voltage across the resistor again sampled. With this approach, there is no way to know what the current in the pacemaker lead will be when the switch closes at the end of the preselected time period. As a result, when the switch closes, it is possible that a current flow in the lead will rise very rapidly. Even if the switch is quickly opened again, a current spike of unknown magnitude can be transmitted to the pacemaker, possibly causing damage, or causing the pacemaker sensor circuitry to misinterpret the status of the heart. U.S. Patent No. 4,102,348 to Hihara discloses an approach similar to that of Suessmilch except that the series switch is implemented as a bipolar transistor, the base voltage of which is supplied by the signal on the pacemaker lead through a resistive voltage divider. The state of the switch depends on the voltage of the signal on the lead. This approach, similarly to the Langer patent provides protection only against unidirec­ tional defibrillation pulses. Accordingly, the present invention has as an object to provide a protection device that protects both a pacemaker or other implantable device and the heart tissue near a lead thereof against damage from high current and voltage levels, particularly those induced by the application of defibrillation pulses. In addition, the present invention had as an object to provide a protection device that switches into the circuit of a pacemaker or other implantable device to limit current in a lead of the device when current exceeds a safe limit, but which is effectively switched out of the circuit during normal operation of the de­ vice. Another object of the present invention is to provide a protection device that provides protection against high-voltage bidirectional or "biphasic" de­ fibrillation pulses. Still another object of the present invention is to provide a protection device that prevents the transmission of possibly dangerous current and voltage spikes to the pacemaker or other device. SUMMARY OF THE INVENTION The above objects and advantages of the present invention are achieved by providing a protection device having a sensor, a switching unit, a controller, and an electrically conductive high-impedance path. The sensor senses the current flowing in at least one of the leads of the electrical device being protected, and generates a signal representative of the current. The controller responds to the signal and causes the switching unit to open the electrically conductive low-impedance path established by the lead when the current flowing in the lead exceeds a safe amplitude. When the electrically conductive low-impedance path is open, current is forced to flow in the electrically conductive high-­ impedance path where it is limited to a safe amplitude. BRIEF DESCRIPTION OF THE DRAWINGS An exemplary illustration of a presently preferred embodiment of the present invention is shown in the accompanying drawings, in which: FIG. 1 is a block diagram illustrating a protection circuit comprising a presently preferred embodiment of the present invention in conjunction with a heart pacemaker and defibrillator unit; FIG. 2 is a schematic diagram of a protection circuit comprising a presently preferred embodiment of the present invention; FIG. 3 is a graph of voltage vs. time illus­ trating a typical biphasic defibrillation pulse train; and FIG. 4 is a graph of current vs. time synchron­ ized with the graph of FIG. 3 and illustrating the cur­ rent typically produced in a pacemaker lead by the pulse train of FIG. 4 with the protection circuit comprising a presently preferred embodiment of the present invention arranged as shown in FIGS. 1 and 2. DETAILED DESCRIPTION OF A PRESENTLY PREFERRED EMBODIMENT The novel features believed to be charac­ teristic of the present invention are set forth in the appended claims. The invention itself, together with further objects and attendant advantages, will best be understood by reference to the following detailed descrip­ tion, which, when taken in conjunction with the accompany­ ing drawings, discloses a presently preferred embodiment of the invention. Referring to FIG. 1, a heart pacemaker 10 implanted in the body of a patient is electrically con­ nected in circuit with the patient's heart 11 via con­ ventional electrically conductive pacing/sensing and return leads 12,13. Pacing/sensing lead 12 contains an electrically conductive barbed or screw-shaped pacing/­ sensing electrode 14 at its distal end for making firm electrical contact with the heart 11. Return lead 13 contains at its distal end a conductive patch 15 which may be sewn to the wall of the heart 11 to ensure a solid electrical connection. Electrically connected between the pacing/sensing and return leads 12,13 are first and second zener diodes 17,18 arranged back to back to limit the voltage differential between the terminals of the pacemaker 10. First zener diode 17 preferably limits the positive voltage differential to approximately +3V. Second zener diode 18 preferably limits the negative differential to approximately -10V. A protection circuit 16 comprising a presently preferred embodiment of the present invention is implanted with the pacemaker 10 and is electrically connected in series with return lead 13 and patch 15 between the heart 11 and the pacemaker 10. In addition, a defibrillator 17, which may be either an external or an implanted unit, is also elec­ trically connected in circuit with the heart 11. If implanted, the defibrillator 17 is electrically connec­ ted to the heart 11 via conventional electrically con­ ductive output and return leads 19,21. Output lead 19 had attached to its distal end a conductive patch 20 which may be sewn to the wall of the heart 11. In this embodiment, return lead 21 is electrically connected at its distal end by any suitable means to return lead 13 between the heart 11 and the protection circuit 16 so that the pacemaker 10 and the defibrillator 17 share a common return lead to some extent. Of course, if the defibrillator 17 is an external unit, then no direct connections to the heart 11 are present. Instead, electrically conductive paddles of a type well known to those skilled in the art are applied externally to the chest of a patient in the vicinity of the heart 11 as output and return electrodes. It is understood that the pacemaker 10 and de­ fibrillator 17 described above are exemplary devices only and that the protection circuit 16 comprising a presently preferred embodiment of the present invention will find use in many other applications where protec­ tion of a device against high voltages and currents is desirable. As illustrated in Fig. 2, the protection cir­ cuit 16 is electrically connected to conductive patch 15 via return lead 13. In series with return lead 13 are a first and a second field effect transistor (FET) 22, 23 and a 5 ohm sensing resistor 24. The drain of the second FET 23 connects to return lead 13 on the heart 11 side. The source of the second FET 23 connects to one end of the sensing resistor 24 and the source of the first FET 22 connects to the opposite end. The drain of the first FET 16 connects to the opposite end of return lead 13 on the pacemaker 10 side. The gates of the first and second FETs 22,23 are connected in parallel to one end of a 390K ohm current limiting resistor 29 and to the collectors of first and second parallel bipolar transistors 25,26. The other end of the 390K ohm current limiting resistor 29 connects to a DC voltage source 30. The emitter of the first bipolar transistor 25 connects to the source of the first FET 22. The emitter of the second bipolar transistor 26 connects to the source of the second FET 23. A first 1K ohm resistor 27 connects the base of the first bipolar transistor 25 with the emitter of the second bipolar transistor 26. Likewise, a second 1k ohm resistor 28 connects the base of the second bipolar transistor with the emitter of the first bipolar transistor 25. The base of the first bipolar transistor 25 also connects to the drain of the second FET 23 through a first 82K ohm resistor 32. Likewise, the base of the second bipolar transistor 26 connects to the drain of the first FET 22 through a second 82K ohm resistor 31. The DC voltage source 30 is preferably derived by a conventional voltage multiplication technique, for example employing switched capacitors, and a miniature long-life battery such as a lithium cell to obtain an output of 8-9VDC. The first and second FETs 22,23 are preferably n-channel FETs and are preferably able to withstand voltages in the 1000 volt range, as well as substantial continuous and peak currents. Also, the first and second FETs 22,23 preferably exhibit very fast turn-off times and good conduction at a relatively low threshold voltage. Further, the FET's are preferably of the type in which the source is internally connected to the substrate. Commercially available Motorola MTM-IN100 n-channel FETs and equivalents, for example, have been found to possess the desired characteristics, and are suitable for use. First and second bipolar transistors 21,22 are preferably conventional, commercially avail­ able NPN transistors such as, for example, 2N2222A transistors. The 5 ohm sensing resistor may be any suitable precision resistor. It should be apparent to those skilled in the art that although the foregoing describes a presently preferred embodiment of the present invention in terms of a positive DC voltage source, n-channel FETs, and NPN bipolar transistors, a protection circuit employing a negative DC voltage source, p-channel FETs, and PNP bipolar transistors constitutes an equally preferred embodiment. Operation of the protection circuit 16 of FIG. 2 will now be described. In the normal pacing/­ sensing mode, the pacing/sensing lead 12 and pacing/­ sensing electrode 14 conduct electrical signals gener­ ated by the heart 11 to the pacemaker 10. If the pace­ maker 10 fails to detect electrical activity in the heart, it generates one or more electrical stimulus pulses 35. A typical stimulus pulse 35 might be, for example, a short duration, rectangular -8V pulse. The pacing/sensing lead 12 and the pacing/sensing electrode 14 conduct these stimulus pulses 35 to the heart 11 to hopefully stimulate cardial activity. In the normal pacing/sensing mode, current in the pacing/sensing and return leads 12,13 typically ranges from approximately .1 to 35 milliamperes. The gates of the first and second FETs 22,23 are held at a positive voltage in excess of the conduction threshold by the DC voltage source 30. The potential at the sources of the first and second FETs 22,23 is substantially lower than at the gates and the first and second FETs conduct current like closed switches with very little impedance. Assum­ ing the current in the return lead 13 is, as stated above, no more than about ±35 milliamperes, the voltage drop across the 5 ohm sensing resistor 24 is insuffi­ cient to forward bias the base-emitter junction of either the first or the second bipolar transistor 25,26 so that neither transistor is conductive. Thus, in the normal pacing/sensing mode, current continues to flow through the low impedance path established by the re­ turn lead 13, the 5 ohm sensing resistor 24, and the first and second FETs 22,23. The high-impedance por­ tion of the protection circuit 16 comprising the 82K ohm and 1K ohm resistors 27, 28, 31, 32 is effectively switched out of the circuit. However, when the heart 11 begins to fibrillate, the condition is sensed by the defibrillator 17 or other monitoring equipment. In response, the defibrillator 17 generates a series of high-voltage pulses which are conducted to the heart 11 via lead 20 or an external paddle. Fig. 3 illustrates a typical biphasic de­ fibrillation pulse train which has been found to be particularly efficacious in arresting defibrillation, and which in addition has been found to impart beneficial post-defibrillation healing effects to the heart. The biphasic pulse train itself forms no part of the present invention but is included herein for the purpose of illustrating various features of the present invention. The typical biphasic defibrillation pulse train may consist of an initial positive pulse 33 rising to a peak of approximately 400 volts in approxima­ tely 50 microseconds, having an on-time of 2-5 milli­ seconds, and a turn off time of approximately 10 micro­ seconds. A second negative pulse 34 of greater magni­ tude typically follows the initial positive pulse 33. The second negative pulse 34 may rise to a peak of approximately -800 volts in approximately 50 micro­ seconds, have an on-time of 5-8 milliseconds, and a turn-off time of approximately 10 microseconds. In some instances, a final positive pulse 35 has been found to impart beneficial healing effects to the de­ fibrillated heart. The final positive high-voltage pulse 35 may rise to a peak voltage of approximately 300 volts in approximately 50 microseconds, have an on-­ time of 2-5 milliseconds, and a turn-off time of approximately 10 microseconds. When the initial positive pulse 33 is applied to the heart 11, the positive potential at the conduc­ tive patch 15 raises rapidly. As illustrated in FIG. 4, this in turn causes the positive current in return lead 13 to rise rapidly, in turn causing the positive voltage drop across the 5 ohm sensing resistor 24 to rise rapidly. When the amplitude of the positive current flow through the sensing resistor 24 reaches approximately .12 amperes resulting in a voltage drop across the sensing resistor 24 of approximately .6 volts, the base-emitter junction of the first bipolar transistor 25 becomes forward biased. The first bipolar transistor 25 then becomes conductive and electrically connects the sources and gates of the first and second FETs 22,23. This in turn causes the conduction channels between the sources and drains of the first and second FETs 22,23 to collapse. However, because each of the FETs has its source and substrate permanently connected internally, at high currents each acts as a diode forward biased between the source and drain. Thus, the second FET 23 acts as a reverse biased diode or open switch to the positive current in return lead 13 while the first FET 22 acts as a forward biased diode to the positive current. As a result, when the normal conduction paths of the first and second FETs 22,23 collapse, the high-impedance portion of the pro­ tection circuit 16 is switched in and an alternate high-­ impedance conduction path in series with the return lead 13 is established. This path comprises the 82K ohm resistor 32, the 1K ohm resistor 25, the 5 ohm sensing resistor 24, and the first FET 22. The switch­ ing of the high-impedance conduction path results in a sharp drop 36 in current to a safe maximum current 36a of approximately 4-5 milliamperes. The first bipolar transistor 25 remains con­ ductive until the positive voltage at the conductive patch 15 drops below approximately 50 volts. At this point, the current flowing in the high-impedance con­ duction path is insufficient to forward bias the base-­ emitter junction of the first bipolar transistor 25, which ceases to conduct. This in turn disconnects the sources and gates of the first and second FETs 22,23, which re-establishes the source to drain conduction channels and allows the FETs 22,23 to once again con­ duct as closed switches. Because the positive poten­ tial at the conductive patch 15 is still approximately 50 volts at this time, a small current surge 37 having a peak magnitude substantially less than the maximum safe amplitude of approximately .12 amperes occurs. When the second negative biphasic pulse 34 is applied to the heart 11, the magnitude of the negative potential at the conductive patch 15 increases rapidly. In turn, the magnitude of the negative current flowing through and the voltage across the 5 ohm sensing resistor 24 also increase rapidly. When the magnitude of the negative current reaches approximately -.12 amperes with a corresponding voltage drop of -.6 volts across the 5 ohm sensing resistor 24, the base-emitter junction of the second bipolar transistor 26 becomes forward biased. The second bipolar transistor 26 then becomes conductive and electrically connects the sources and gates of the first and second FETs 22,23. This in turn causes the source to drain conduction paths in the FETs 22,23 to collapse. In this case, the first FET 22 acts as a reverse biased diode or open switch to the negative current while the second FET 23 acts as a forward biased diode. As a result, the high-impedance portion of the protection circuit 16 is switched in and an alternate high-impedance conduction path for the negative current is established. This path comprises the 82K ohm resistor 31, the 1K ohm resistor 28, the 5 ohm sensing resistor 24, and the second FET 23. The 82K ohm resistor 31, the 1K ohm resistor 28, the 5 ohm sensing resistor 24, the collector-emitter path of the second bipolar tran­ sistor 26, and the 390K ohm resistor 29 establish a parallel high-impedance path for the negative current. The switching in of the parallel high-impedance conduc­ tion paths results in a sharp decline 38 in the current of the negative current to a safe maximum amplitude 38a of less than 10 milliamperes as illustrated in Fig. 4. The second bipolar transistor 26 remains con­ ductive until the magnitude of the negative potential at the conductive patch 15 drops to approximately -50 volts. At this point, the negative current flowing in the parallel, high-impedance paths is insufficient to forward bias the base-emitter junction of the second bipolar transistor 26, which ceases to conduct. This in turn disconnects the sources and gates of the first and second FETs 25,26, which re-establishes the source to drain conduction channels and causes the FETs 25,26 to again conduct as closed switches. Because the nega­ tive potential at the conductive patch 15 is still ap­ proximately -50 volts at this time, a small negative current surge 39 having a peak magnitude substantially less than the maximum safe amplitude of approximately -.12 amperes occurs. Operation of the protection circuit 16 for subsequent positive and negative defibrillation pulses including pulse 35 of Fig. 3 is identical. In addi­ tion, the presently preferred embodiment of the protec­ tion circuit 16 operates the same regardless of whether the defibrillator pulses are directly applied to the heart 11 as illustrated in Fig. 1, or are applied ex­ ternally via conductive paddles as described above. Operation of the presently preferred embodiment of the protection circuit is also independent of the manner of pacing and sensing employed. Of course it should be understood that the apparatus described herein in detail is merely illus­ trative of various aspects of the present invention and is not intended to be limiting. Various changes to the preferred embodiments described herein will be apparent to those skilled in the art. Such changes and modifica­ tions can be made without departing from the spirit and scope of the present invention. It is, therefore, in­ tended that such changes and modifications be covered by the following claims and their equivalents.

Claims: 1. An apparatus for protecting an implantable electrical device having a plurality of electrically conductive leads against excessive currents and voltages on said leads, comprising means for sensing the current flowing in at least one of said leads, and for generating a signal representative of that current; switch means for opening and closing an elec­ trically conductive low-impedance path established at least partially by said at least one of said leads; means responsive to said signal representa­ tive of said current for controlling said switch means to open said electrically conductive low-impedance path when said current exceeds a predetermined level; and means establishing at least one alternate, electrically conductive high-impedance path in which said current flows when said electrically conductive low-impedance path is open, whereby the current flowing into said electrical device is limited to a safe level. 2. The apparatus of Claim 1 further comprising means for limiting the maximum voltage between the out­ put and return terminals of said electrical device to a predetermined safe level. 3. The apparatus of Claim 1 wherein said means for sensing said current and for generating a signal representative thereof comprises a sensing resistor. 4. The apparatus of Claim 1 wherein said switch means comprises first switch means for opening said electrically conductive low-impedance path when said signal representative of said current exceeds a first predetermined positive amplitude, and second switch means for opening said electrically conductive low-­ impedance path when said signal representative of said current exceeds a second predetermined negative ampli­ tude. 5. The apparatus of Claim 1 wherein said switch means and said means for sensing current are in electrical series with said electrically conductive low-impedance path established at least partially by said at least one of said leads. 6. The apparatus of Claim 4 wherein said means for controlling said switch means comprises first con­ trol means for controlling said first switch means to open said first switch means when said current exceeds a predetermined positive amplitude, and second control means for controlling said second switch means to open said second switch means when said current exceeds a predetermined negative amplitude. 7. The apparatus of Claim 6 wherein: said first switch means comprises a first field effect transistor and said second switch means comprises a second field effect transistor; said first control means comprises a first transistor arranged to electrically connect the gates and sources of said first and second field effect transistors when said current exceeds a predetermined positive amplitude; and said second control means comprises a second transistor arranged to electrically connect the gates and sources of said first and second field effect transistors when said current exceeds a predetermined negative amplitude. 8. The apparatus of Claim 4 wherein said first means for opening said electrically conductive low-­ impedance path forms part of said alternate, electric­ ally conductive high-impedance path when said current exceeds a predetermined positive amplitude, and wherein said second means for opening said electrically conduc­ tive path forms part of said alternate, electrically conductive high-impedance path when said current exceeds a predetermined negative amplitude. 9. A patient implantable apparatus for assisting the proper functioning of the patient's heart, com­ prising: pacemaker means for receiving signals representative of the activity of the patient's heart and for transmitting electrical stimulus signals to the heart to stimulate activity; a plurality of electrically conductive low-impedance leads connected to the patients's heart, and to the pacemaker means for communicating said elec­ trical signals representative of the activity of the heart to the pacemaker means, and for communicating said electrical stimulus signals from said pacemaker means to the heart; and means for protecting said pacer means against damage from excessive currents and voltages on said plurality of leads comprising: means for sensing the current flowing in at least one of said leads, and for generating a signal representative of that current; switch means for opening and closing an elec­ trically conductive low-impedance path established at least partially by said at least one of said leads; means responsive to said signal representa­ tive of said current for controlling said switch means to open said electrically conductive low-impedance path when said current exceeds a predetermined level; and means establishing an alternate, electrically conductive high-impedance path in which said current flows when said electrically conductive low-impedance path is open, whereby the current flowing into said pacemaker means is limited to a safe level. 10. The apparatus of Claim 9 comprising means for limiting the maximum voltage between the terminals of said pacemaker means to a predetermined safe level. 11. The apparatus of Claim 9 wherein said means for sensing said current and for generating a signal representative thereof comprises a sensing resistor. 12. The apparatus of Claim 9 wherein said switch means comprises first switch means for opening said electrically conductive low-impedance path when said signal representative of said current exceeds a first predetermined positive amplitude, and second switch means for opening said electrically conductive low-­ impedance path when said signal representative of said current exceeds a second predetermined negative ampli­ tude. 13. The apparatus of Claim 9 wherein said switch means and said means for sensing current are in electrical series with said electrically conductive low-impedance path established at least partially by said at least one of said leads. 14. The apparatus of Claim 12 wherein said means for controlling said switch means comprises first con­ trol means for controlling said first switch means to open said first switch means when said current exceeds a predetermined positive amplitude, and second control means for controlling said second switch means to open said second switch means when said current exceeds a predetermined negative amplitude. 15. The apparatus of Claim 13 wherein: said first switch means comprises a first field effect transistor and said second switch means comprises a second field effect transistor; said first control means comprises a first transistor arranged to electrically connect the gates and sources of said first and second field effect transistors when said current exceeds a predetermined positive amplitude; and said second control means comprises a second transistor arranged to electrically connect the gates and sources of said first and second field effect transistors when said current exceeds a predetermined negative amplitude. 16. The apparatus of Claim 12 wherein said first means for opening said electrically conductive low-­ impedance path forms part of said alternate, electric­ ally conductive high-impedance path when said current exceeds a predetermined positive amplitude, and wherein said second means for opening said electrically conduc­ tive low-impedance path forms part of said alternate, electrically conductive high-impedance path when said current exceeds a predetermined negative amplitude.

Inventors: WINSTROM, WILLIAM LEON
Applicants: INTERMEDICS, INC.
Application year: 1986
Main classification: A61N1
IPC codes: H02H9, A61N1